<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00880958</url>
  </required_header>
  <id_info>
    <org_study_id>eki-123</org_study_id>
    <nct_id>NCT00880958</nct_id>
  </id_info>
  <brief_title>Effects of Supplement Containing Various Probiotics and Fermentation Products on Obesity</brief_title>
  <official_title>Effects of Supplement Containing Various Probiotics and Fermentation Products on Obesity: a Double-Blind, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hiroshima University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biostir, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>MIONA Co., Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hiroshima University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of supplement combined various
      probiotics and fermentation products on body mass index, body fat mass, abdominal
      circumference, visceral fat mass, intestinal flora, and serum biochemical parameters in
      overweight subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body mass index</measure>
    <time_frame>16 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body fat mass</measure>
    <time_frame>Week -4, Week 0, Week 4, Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abdominal circumference</measure>
    <time_frame>Week -4, Week 0, Week 4, Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visceral fat area by CT scan</measure>
    <time_frame>Week 0, Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intestinal flora</measure>
    <time_frame>Week 0, Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum lipid profile</measure>
    <time_frame>Week -4, Week 0, Week 4, Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum adiponectin and leptin levels</measure>
    <time_frame>Week 0, Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting serum glucose and HbA1c levels</measure>
    <time_frame>Week -4, Week 0, Week 4, Week 12</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Mixture of various probiotics and fermentation products</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy as based on medical history and physical examination

          -  BMI between 25 and 30 kg/m2

          -  Willing not to serve as blood donor during the study

          -  Informed consent signed

        Exclusion Criteria:

          -  Food allergy

          -  Female subjects who are pregnant or nursing a child

          -  Participation in any clinical trial up to 90 days before Day 01 of this study

          -  Renal or hepatic dysfunction

          -  Heart disease

          -  Under medication

          -  Subjects who are taking functional food designed for weight loss or serum lipid
             reduction
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hiroshima University</name>
      <address>
        <city>Hiroshima</city>
        <zip>734-8551</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2009</study_first_submitted>
  <study_first_submitted_qc>April 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2009</study_first_posted>
  <last_update_submitted>October 28, 2009</last_update_submitted>
  <last_update_submitted_qc>October 28, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Fumiko Higashikawa, PhD/Associate professor</name_title>
    <organization>Hiroshima University</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

